2.4.0.6 Html 268 286 1 true 65 0 false 5 false false R1.htm 00000 - Document - Document and Entity Information Sheet http://www.oncosec.com/role/DocumentAndEntityInformation Document and Entity Information true false R2.htm 10010 - Statement - Consolidated Balance Sheets Sheet http://www.oncosec.com/role/BalanceSheet Consolidated Balance Sheets false false R3.htm 10015 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://www.oncosec.com/role/BalanceSheetParenthetical Consolidated Balance Sheets (Parenthetical) false false R4.htm 10020 - Statement - Consolidated Statements of Operations Sheet http://www.oncosec.com/role/StatementOfIncome Consolidated Statements of Operations false false R5.htm 10030 - Statement - Consolidated Statements of Stockholders' Equity (Deficit) Sheet http://www.oncosec.com/role/StatementsOfStockholdersEquity Consolidated Statements of Stockholders' Equity (Deficit) false false R6.htm 10035 - Statement - Consolidated Statements of Stockholders' Equity (Deficit) (Parenthetical) Sheet http://www.oncosec.com/role/StatementsOfStockholdersEquityParenthetical Consolidated Statements of Stockholders' Equity (Deficit) (Parenthetical) false false R7.htm 10040 - Statement - Consolidated Statements of Cash Flows Sheet http://www.oncosec.com/role/CashFlows Consolidated Statements of Cash Flows false false R8.htm 11010 - Disclosure - Nature of Operations and Basis of Presentation Sheet http://www.oncosec.com/role/DisclosureNatureOfOperationsAndBasisOfPresentation Nature of Operations and Basis of Presentation false false R9.htm 11020 - Disclosure - Significant Accounting Policies Sheet http://www.oncosec.com/role/DisclosureSignificantAccountingPolicies Significant Accounting Policies false false R10.htm 11030 - Disclosure - Cash and Liquidity Sheet http://www.oncosec.com/role/DisclosureCashAndLiquidity Cash and Liquidity false false R11.htm 11040 - Disclosure - Fair Value of Financial Instruments Sheet http://www.oncosec.com/role/DisclosureFairValueOfFinancialInstruments Fair Value of Financial Instruments false false R12.htm 11050 - Disclosure - Intangible Asset Acquisition and Cross License Agreement Sheet http://www.oncosec.com/role/DisclosureIntangibleAssetAcquisitionAndCrossLicenseAgreement Intangible Asset Acquisition and Cross License Agreement false false R13.htm 11060 - Disclosure - Acquisition Obligation Sheet http://www.oncosec.com/role/DisclosureAcquisitionObligation Acquisition Obligation false false R14.htm 11070 - Disclosure - Private Placements and Public Offering Sheet http://www.oncosec.com/role/DisclosurePrivatePlacementsAndPublicOffering Private Placements and Public Offering false false R15.htm 11080 - Disclosure - Other Equity and Common Stock Transactions Sheet http://www.oncosec.com/role/DisclosureOtherEquityAndCommonStockTransactions Other Equity and Common Stock Transactions false false R16.htm 11090 - Disclosure - Stock-Based Compensation Sheet http://www.oncosec.com/role/DisclosureStockBasedCompensation Stock-Based Compensation false false R17.htm 11100 - Disclosure - Income Taxes Sheet http://www.oncosec.com/role/DisclosureIncomeTaxes Income Taxes false false R18.htm 11110 - Disclosure - Commitments and Contingencies Sheet http://www.oncosec.com/role/DisclosureCommitmentsAndContingencies Commitments and Contingencies false false R19.htm 11120 - Disclosure - Related Party Transactions Sheet http://www.oncosec.com/role/DisclosureRelatedPartyTransactions Related Party Transactions false false R20.htm 12020 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.oncosec.com/role/DisclosureSignificantAccountingPoliciesPolicies Significant Accounting Policies (Policies) false false R21.htm 13020 - Disclosure - Significant Accounting Policies (Tables) Sheet http://www.oncosec.com/role/DisclosureSignificantAccountingPoliciesTables Significant Accounting Policies (Tables) false false R22.htm 13040 - Disclosure - Fair Value of Financial Instruments (Tables) Sheet http://www.oncosec.com/role/DisclosureFairValueOfFinancialInstrumentsTables Fair Value of Financial Instruments (Tables) false false R23.htm 13050 - Disclosure - Intangible Asset Acquisition and Cross License Agreement (Tables) Sheet http://www.oncosec.com/role/DisclosureIntangibleAssetAcquisitionAndCrossLicenseAgreementTables Intangible Asset Acquisition and Cross License Agreement (Tables) false false R24.htm 13070 - Disclosure - Private Placements and Public Offering (Tables) Sheet http://www.oncosec.com/role/DisclosurePrivatePlacementsAndPublicOfferingTables Private Placements and Public Offering (Tables) false false R25.htm 13090 - Disclosure - Stock-Based Compensation (Tables) Sheet http://www.oncosec.com/role/DisclosureStockBasedCompensationTables Stock-Based Compensation (Tables) false false R26.htm 13100 - Disclosure - Income Taxes (Tables) Sheet http://www.oncosec.com/role/DisclosureIncomeTaxesTables Income Taxes (Tables) false false R27.htm 14010 - Disclosure - Nature of Operations and Basis of Presentation (Details) Sheet http://www.oncosec.com/role/DisclosureNatureOfOperationsandBasisOfPresentationDetails Nature of Operations and Basis of Presentation (Details) false false R28.htm 14020 - Disclosure - Significant Accounting Policies (Details) Sheet http://www.oncosec.com/role/DisclosureSignificantAccountingPoliciesDetails Significant Accounting Policies (Details) false false R29.htm 14021 - Disclosure - Significant Accounting Policies (Details 2) Sheet http://www.oncosec.com/role/DisclosureSignificantAccountingPoliciesDetails2 Significant Accounting Policies (Details 2) false false R30.htm 14030 - Disclosure - Cash and Liquidity (Details) Sheet http://www.oncosec.com/role/DisclosureCashAndLiquidityDetails Cash and Liquidity (Details) false false R31.htm 14040 - Disclosure - Fair Value of Financial Instruments (Details) Sheet http://www.oncosec.com/role/DisclosureFairValueOfFinancialInstrumentsDetails Fair Value of Financial Instruments (Details) false false R32.htm 14041 - Disclosure - Fair Value of Financial Instruments (Details 2) Sheet http://www.oncosec.com/role/DisclosureFairValueOfFinancialInstrumentsDetails2 Fair Value of Financial Instruments (Details 2) false false R33.htm 14050 - Disclosure - Intangible Asset Acquisition and Cross License Agreement (Details) Sheet http://www.oncosec.com/role/DisclosureIntangibleAssetAcquisitionAndCrossLicenseAgreementDetails Intangible Asset Acquisition and Cross License Agreement (Details) false false R34.htm 14060 - Disclosure - Acquisition Obligation (Details) Sheet http://www.oncosec.com/role/DisclosureAcquisitionObligationDetails Acquisition Obligation (Details) false false R35.htm 14061 - Disclosure - Acquisition Obligation (Details 2) Sheet http://www.oncosec.com/role/DisclosureAcquisitionObligationDetails2 Acquisition Obligation (Details 2) false false R36.htm 14070 - Disclosure - Private Placements and Public Offering (Details) Sheet http://www.oncosec.com/role/DisclosurePrivatePlacementsAndPublicOfferingDetails Private Placements and Public Offering (Details) false false R37.htm 14071 - Disclosure - Private Placements and Public Offering (Details 2) Sheet http://www.oncosec.com/role/DisclosurePrivatePlacementsAndPublicOfferingDetails2 Private Placements and Public Offering (Details 2) false false R38.htm 14080 - Disclosure - Other Equity and Common Stock Transactions (Details) Sheet http://www.oncosec.com/role/DisclosureOtherEquityAndCommonStockTransactionsDetails Other Equity and Common Stock Transactions (Details) false false R39.htm 14090 - Disclosure - Stock-Based Compensation (Details) Sheet http://www.oncosec.com/role/DisclosureStockBasedCompensationDetails Stock-Based Compensation (Details) false false R40.htm 14091 - Disclosure - Stock-Based Compensation (Details 2) Sheet http://www.oncosec.com/role/DisclosureStockBasedCompensationDetails2 Stock-Based Compensation (Details 2) false false R41.htm 14100 - Disclosure - Income Taxes (Details) Sheet http://www.oncosec.com/role/DisclosureIncomeTaxesDetails Income Taxes (Details) false false R42.htm 14101 - Disclosure - Income Taxes (Details 2) Sheet http://www.oncosec.com/role/DisclosureIncomeTaxesDetails2 Income Taxes (Details 2) false false R43.htm 14102 - Disclosure - Income Taxes (Details 3) Sheet http://www.oncosec.com/role/DisclosureIncomeTaxesDetails3 Income Taxes (Details 3) false false R44.htm 14110 - Disclosure - Commitments and Contingencies (Details) Sheet http://www.oncosec.com/role/DisclosureCommitmentsAndContingenciesDetails Commitments and Contingencies (Details) false false R45.htm 14120 - Disclosure - Related Party Transactions (Details) Sheet http://www.oncosec.com/role/DisclosureRelatedPartyTransactionsDetails Related Party Transactions (Details) false false R46.htm 20010 - Statement - Consolidated Balance Sheets Sheet http://www.oncosec.com/role/BalanceSheetQuarterEnd Consolidated Balance Sheets false false R47.htm 20015 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://www.oncosec.com/role/BalanceSheetParentheticalQuarterEnd Consolidated Balance Sheets (Parenthetical) false false R48.htm 20020 - Statement - Consolidated Statements of Operations Sheet http://www.oncosec.com/role/StatementOfIncomeQuarterEnd Consolidated Statements of Operations false false R49.htm 20030 - Statement - Consolidated Statements of Stockholders' Equity (Deficit) Sheet http://www.oncosec.com/role/StatementsOfStockholdersEquityQuarterEnd Consolidated Statements of Stockholders' Equity (Deficit) false false R50.htm 20035 - Statement - Consolidated Statements of Stockholders' Equity (Deficit) (Parenthetical) Sheet http://www.oncosec.com/role/StatementsOfStockholdersEquityParentheticalQuarterEnd Consolidated Statements of Stockholders' Equity (Deficit) (Parenthetical) false false R51.htm 20040 - Statement - Consolidated Statements of Cash Flows Sheet http://www.oncosec.com/role/CashFlowsQuarterEnd Consolidated Statements of Cash Flows false false R52.htm 21010 - Disclosure - Nature of Operations and Basis of Presentation Sheet http://www.oncosec.com/role/DisclosureNatureOfOperationsAndBasisOfPresentationQuarterEnd Nature of Operations and Basis of Presentation false false R53.htm 21020 - Disclosure - Significant Accounting Policies Sheet http://www.oncosec.com/role/DisclosureSignificantAccountingPoliciesQuarterEnd Significant Accounting Policies false false R54.htm 21030 - Disclosure - Cash and Cash Equivalents and Liquidity Sheet http://www.oncosec.com/role/DisclosureCashAndCashEquivalentsAndLiquidityQuarterEnd Cash and Cash Equivalents and Liquidity false false R55.htm 21040 - Disclosure - Fair Value of Financial Instruments Sheet http://www.oncosec.com/role/DisclosureFairValueOfFinancialInstrumentsQuarterEnd Fair Value of Financial Instruments false false R56.htm 21050 - Disclosure - Intangible Asset Acquisition and Cross License Agreement Sheet http://www.oncosec.com/role/DisclosureIntangibleAssetAcquisitionAndCrossLicenseAgreementQuarterEnd Intangible Asset Acquisition and Cross License Agreement false false R57.htm 21060 - Disclosure - Acquisition Obligation Sheet http://www.oncosec.com/role/DisclosureAcquisitionObligationQuarterEnd Acquisition Obligation false false R58.htm 21070 - Disclosure - Private Placements and Public Offerings Sheet http://www.oncosec.com/role/DisclosurePrivatePlacementsAndPublicOfferingsQuarterEnd Private Placements and Public Offerings false false R59.htm 21080 - Disclosure - Other Equity and Common Stock Transactions Sheet http://www.oncosec.com/role/DisclosureOtherEquityAndCommonStockTransactionsQuarterEnd Other Equity and Common Stock Transactions false false R60.htm 21090 - Disclosure - Stock-Based Compensation Sheet http://www.oncosec.com/role/DisclosureStockBasedCompensationQuarterEnd Stock-Based Compensation false false R61.htm 21100 - Disclosure - Income Taxes Sheet http://www.oncosec.com/role/DisclosureIncomeTaxesQuarterEnd Income Taxes false false R62.htm 21110 - Disclosure - Commitments and Contingencies Sheet http://www.oncosec.com/role/DisclosureCommitmentsAndContingenciesQuarterEnd Commitments and Contingencies false false R63.htm 21120 - Disclosure - Related Party Transactions Sheet http://www.oncosec.com/role/DisclosureRelatedPartyTransactionsQuarterEnd Related Party Transactions false false R64.htm 21130 - Disclosure - Subsequent Event Sheet http://www.oncosec.com/role/DisclosureSubsequentEventQuarterEnd Subsequent Event false false R65.htm 22020 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.oncosec.com/role/DisclosureSignificantAccountingPoliciesPoliciesQuarterEnd Significant Accounting Policies (Policies) false false R66.htm 23020 - Disclosure - Significant Accounting Policies (Tables) Sheet http://www.oncosec.com/role/DisclosureSignificantAccountingPoliciesTablesQuarterEnd Significant Accounting Policies (Tables) false false R67.htm 23050 - Disclosure - Intangible Asset Acquisition and Cross License Agreement (Tables) Sheet http://www.oncosec.com/role/DisclosureIntangibleAssetAcquisitionAndCrossLicenseAgreementTablesQuarterEnd Intangible Asset Acquisition and Cross License Agreement (Tables) false false R68.htm 23070 - Disclosure - Private Placements and Public Offerings (Tables) Sheet http://www.oncosec.com/role/DisclosurePrivatePlacementsAndPublicOfferingsTablesQuarterEnd Private Placements and Public Offerings (Tables) false false R69.htm 23090 - Disclosure - Stock-Based Compensation (Tables) Sheet http://www.oncosec.com/role/DisclosureStockBasedCompensationTablesQuarterEnd Stock-Based Compensation (Tables) false false R70.htm 24010 - Disclosure - Nature of Operations and Basis of Presentation (Details) Sheet http://www.oncosec.com/role/DisclosureNatureOfOperationsAndBasisOfPresentationDetailsQuarterEnd Nature of Operations and Basis of Presentation (Details) false false R71.htm 24020 - Disclosure - Significant Accounting Policies (Details) Sheet http://www.oncosec.com/role/DisclosureSignificantAccountingPoliciesDetailsQuarterEnd Significant Accounting Policies (Details) false false R72.htm 24021 - Disclosure - Significant Accounting Policies (Details 2) Sheet http://www.oncosec.com/role/DisclosureSignificantAccountingPoliciesDetails2QuarterEnd Significant Accounting Policies (Details 2) false false R73.htm 24030 - Disclosure - Cash and Cash Equivalents and Liquidity (Details) Sheet http://www.oncosec.com/role/DisclosureCashAndCashEquivalentsAndLiquidityDetailsQuarterEnd Cash and Cash Equivalents and Liquidity (Details) false false R74.htm 24040 - Disclosure - Fair Value of Financial Instruments (Details) Sheet http://www.oncosec.com/role/DisclosureFairValueOfFinancialInstrumentsDetailsQuarterEnd Fair Value of Financial Instruments (Details) false false R75.htm 24050 - Disclosure - Intangible Asset Acquisition and Cross License Agreement (Details) Sheet http://www.oncosec.com/role/DisclosureIntangibleAssetAcquisitionAndCrossLicenseAgreementDetailsQuarterEnd Intangible Asset Acquisition and Cross License Agreement (Details) false false R76.htm 24060 - Disclosure - Acquisition Obligation (Details) Sheet http://www.oncosec.com/role/DisclosureAcquisitionObligationDetailsQuarterEnd Acquisition Obligation (Details) false false R77.htm 24061 - Disclosure - Acquisition Obligation (Details 2) Sheet http://www.oncosec.com/role/DisclosureAcquisitionObligationDetails2QuarterEnd Acquisition Obligation (Details 2) false false R78.htm 24070 - Disclosure - Private Placements and Public Offerings (Details) Sheet http://www.oncosec.com/role/DisclosurePrivatePlacementsAndPublicOfferingsDetailsQuarterEnd Private Placements and Public Offerings (Details) false false R79.htm 24071 - Disclosure - Private Placements and Public Offerings (Details 2) Sheet http://www.oncosec.com/role/DisclosurePrivatePlacementsAndPublicOfferingsDetails2QuarterEnd Private Placements and Public Offerings (Details 2) false false R80.htm 24080 - Disclosure - Other Equity and Common Stock Transactions (Details) Sheet http://www.oncosec.com/role/DisclosureOtherEquityAndCommonStockTransactionsDetailsQuarterEnd Other Equity and Common Stock Transactions (Details) false false R81.htm 24081 - Disclosure - Other Equity and Common Stock Transactions (Details 2) Sheet http://www.oncosec.com/role/DisclosureOtherEquityAndCommonStockTransactionsDetails2QuarterEnd Other Equity and Common Stock Transactions (Details 2) false false R82.htm 24090 - Disclosure - Stock-Based Compensation (Details) Sheet http://www.oncosec.com/role/DisclosureStockBasedCompensationDetailsQuarterEnd Stock-Based Compensation (Details) false false R83.htm 24091 - Disclosure - Stock-Based Compensation (Details 2) Sheet http://www.oncosec.com/role/DisclosureStockBasedCompensationDetails2QuarterEnd Stock-Based Compensation (Details 2) false false R84.htm 24110 - Disclosure - Commitments and Contingencies (Details) Sheet http://www.oncosec.com/role/DisclosureCommitmentsAndContingenciesDetailsQuarterEnd Commitments and Contingencies (Details) false false R85.htm 24130 - Disclosure - Subsequent Event (Details) Sheet http://www.oncosec.com/role/DisclosureSubsequentEventDetailsQuarterEnd Subsequent Event (Details) false false All Reports Book All Reports Element oncs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate had a mix of decimals attribute values: 2 4. Element oncs_StockIssuanceCostsPlacementExpenseReimbursementPercentage had a mix of decimals attribute values: 0 2. Element us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights had a mix of decimals attribute values: 2 4. Element us-gaap_FairValueAssumptionsExpectedVolatilityRate had a mix of decimals attribute values: 3 4. Process Flow-Through: 10010 - Statement - Consolidated Balance Sheets Process Flow-Through: Removing column 'Apr. 30, 2013' Process Flow-Through: Removing column 'Jul. 31, 2012' Process Flow-Through: Removing column 'Apr. 30, 2012' Process Flow-Through: Removing column 'Jul. 31, 2010' Process Flow-Through: Removing column 'Jul. 31, 2009' Process Flow-Through: Removing column 'Jul. 31, 2008' Process Flow-Through: 10015 - Statement - Consolidated Balance Sheets (Parenthetical) Process Flow-Through: 10020 - Statement - Consolidated Statements of Operations Process Flow-Through: 10035 - Statement - Consolidated Statements of Stockholders' Equity (Deficit) (Parenthetical) Process Flow-Through: 10040 - Statement - Consolidated Statements of Cash Flows Process Flow-Through: 20010 - Statement - Consolidated Balance Sheets Process Flow-Through: 20015 - Statement - Consolidated Balance Sheets (Parenthetical) Process Flow-Through: 20020 - Statement - Consolidated Statements of Operations Process Flow-Through: Removing column '6 Months Ended Jul. 31, 2008' Process Flow-Through: Removing column '12 Months Ended Jul. 31, 2012' Process Flow-Through: Removing column '12 Months Ended Jul. 31, 2011' Process Flow-Through: Removing column '12 Months Ended Jul. 31, 2010' Process Flow-Through: Removing column '12 Months Ended Jul. 31, 2009' Process Flow-Through: Removing column '54 Months Ended Jul. 31, 2012' Process Flow-Through: 20035 - Statement - Consolidated Statements of Stockholders' Equity (Deficit) (Parenthetical) Process Flow-Through: 20040 - Statement - Consolidated Statements of Cash Flows Process Flow-Through: Removing column '9 Months Ended Apr. 30, 2012' Process Flow-Through: Removing column '12 Months Ended Jul. 31, 2012' Process Flow-Through: Removing column '12 Months Ended Jul. 31, 2011' Process Flow-Through: Removing column '54 Months Ended Jul. 31, 2012' oncs-20130619.xml oncs-20130619.xsd oncs-20130619_cal.xml oncs-20130619_def.xml oncs-20130619_lab.xml oncs-20130619_pre.xml true true